Skip to main content
Advertisement
Advertisement

Guardant Health (GH) Price Forecast: Breakout Opens Path Toward $250

By: 
Bruce Powers

Key Points:

  • Long-term breakout gains momentum
  • Record high confirms bullish strength
  • Multiple timeframes align bullishly
  • Fibonacci targets reach $217.17
  • Measured target points toward $249.74

Long-Term Breakout Gains Momentum

Guardant Health, Inc. (GH), a precision oncology company, extended its recent breakout from a long-term basing pattern on Monday, suggesting that a new leg higher may be beginning. A new record high of $187.38 was reached on Monday after an initial multi-year breakout above the 2021 high of $181.07 triggered in mid-September. Following that initial bullish trend continuation signal, GH consolidated in a relatively tight range near its highs. That consolidation followed a longer ascending triangle formation that preceded the September breakout, providing another bullish continuation signal.

GH daily chart shows new high breakout of consolidation
GH daily chart shows new high breakout of consolidation

Bullish Patterns Align Across Timeframes

Together, these patterns show a long-term upside breakout accompanied by bullish signals from two shorter-term consolidation patterns. The longer and shorter timeframes are in sync, which could make bullish follow-through more powerful if buyers maintain control.

GH weekly chart shows long-term bullish trend
GH weekly chart shows long-term bullish trend

Fibonacci Targets Map Further Upside

Regardless of what follows, key support has been defined by this week’s higher weekly low of $176.37. The breakout was further confirmed with a daily close above $183.50 on Monday at $187.22, establishing a new record daily closing price for the stock. Several potential initial upside targets are suggested by Fibonacci extensions of prior downswings at $195.88, $213.12, and $217.17. However, the measuring objective from the ascending triangle pattern suggests an eventual upside target near $235.88.

Moving-Average Test Confirms Buyer Strength

Technically, GH is in a powerful position given the bullish pattern alignment across multiple timeframes. If buyers can maintain control above key support, upside follow-through would be consistent with the long-term bullish trend. Smaller bullish confirmation signals include the pullback and subsequent rejection of GH at the 20-day moving average on Friday.

Weakness during that day broke below a seven-day support range before reversing to the upside near the 20-day moving average. A pullback followed by a successful test and rejection of support near a key moving average after a consolidation breakout is typical bullish behavior in a strong stock.

Shortening Consolidations Point Toward $250

The progression from a larger ascending triangle to a smaller bullish flag shows improving underlying momentum. Consolidation is shortening, which reflects increasingly aggressive buyer behavior. In this case, a sharp measured move is estimated using a conservative approach, based on an advance of at least 75.8% that preceded the ascending triangle formation.

That distance added to the $174.08 breakout level points to approximately $249.74. This measured-move objective, together with the Fibonacci targets above, provides additional upside potential if GH can sustain its breakout. The immediate test remains whether buyers can defend $176.37 and keep the stock above its breakout structure.

If you’d like to know more about technical analysis and how traders use it, please visit our educational area.

About the Author

Bruce PowersSenior Analyst

With over 20 years of experience in financial markets, Bruce is a seasoned finance MBA and CMT® charter holder. Having worked as head of trading strategy at hedge funds and a corporate advisor for trading firms, Bruce shares his expertise in futures to retail investors, providing actionable insights through both technical and fundamental analyses.

Advertisement